The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Breakthrough Thermal Technology

December 6, 2012 9:30 am | Thermacore, Inc. | Product Releases | Comments

Thermacore, Inc., a leading provider of advanced thermal solutions, is offering a new generation of compact, custom-built, high-performance air-cooled heat sinks, the result of a multimillion-dollar development contract...

Bio-Path Holdings to Expand Development of Liposomal Grb-2 into two Additional Indications: Triple Negative and Inflammatory Breast Cancers

December 6, 2012 9:30 am | by The Associated Press | News | Comments

HOUSTON--(BUSINESS WIRE)--Dec 6, 2012--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced it is initiating development of its lead cancer drug BP-100-1.01 (Liposomal Grb-2) to treat...

ITE Certified 10 to 30-Watt Switchers

December 6, 2012 9:25 am | Tdk - Lambda Americas | Product Releases | Comments

TDK Corporation announces the release of TDK-Lambda’s new ZWS10-30B Series of open-frame, 2-inch wide power supplies, with output power ratings of 10, 15, and 30-watts.


Design and Rapid Prototyping Services

December 6, 2012 9:14 am | Graphicast, Inc. | Product Releases | Comments

Graphicast, Inc., a contract casting house, now offers design and rapid prototyping services to assist engineers in designing parts as castings from the start, maximizing as-cast features to shorten time-to-market and reduce the costs of development, machining, and production.

Fiber-Pigtailed Sapphire Lasers

December 6, 2012 9:10 am | Coherent Semiconductor Group | Product Releases | Comments

Coherent Inc. has introduced a new range of fiber-pigtailed (FP) lasers into its well-established portfolio of FP products. The new Sapphire™ FP lasers are compact, CW, visible lasers that offer...

Chemotherapy After Complete Surgical Removal of Local or Regional Breast Cancer Recurrence Increased Survival Rates

December 6, 2012 8:30 am | by AACR | News | Comments

Disease-free and overall survival improved with postsurgical chemotherapy. Patients with ER-negative breast cancers were most responsive to treatment. SAN ANTONIO — Chemotherapy after surgery, or adjuvant chemotherapy, led to higher rates of disease-free and overall survival for women with isolated local or regional recurrence of breast cancer, according to data presented at the 2012 CTRC-AACR [...]

Medidata Solutions Partners with Veeva Systems to Bring Integrated eTMF to the Clinical Cloud

December 6, 2012 8:30 am | by The Associated Press | News | Comments

NEW YORK--(BUSINESS WIRE)--Dec 6, 2012--Veeva Systems has partnered with Medidata Solutions (NASDAQ: MDSO) to offer the life science industry’s first cloud-based end-to-end solution that integrates clinical documentation and trial development. The two companies will integrate Vault eTMF, Veeva’s...

House bill calls for an FDA mobile medical health division | On Call

December 6, 2012 7:29 am | by Mass Device | News | Comments

House Representative Mike Honda (D-Calif.) introduces a bill that would create an FDA office tasked with managing wireless health. Representative Mike Honda (D-Calif.) introduced a bill on the House floor designed to give a boost to health information technology, including wireless health programs.


Separation Design Group Launches Crowd-Funding Campaign for World's Smallest Oxygen Machine

December 6, 2012 6:28 am | by Bio-Medicine.Org | News | Comments

WAYNESBURG, Pa., Dec. 06, 2012 /- Privately held research and development laboratory Separation Design Group, LLC (SDGroup) has developed the world's smallest oxygen machine. The O-Pal Personal Beverage Oxygenator is a handheld appliance that extracts oxygen from the air and injects it into beverages to improve flavor. The patent-pending device harvests oxygen directly from the ai...

uniQure Appoints Hans Christian Rohde Chief Commercial Officer

December 6, 2012 3:20 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM, The Netherlands, December 6, 2012 /- uniQure B.V., a leader in the field of human gene therapy, today announced the appointment of Hans Christian Rohde as Chief Commercial Officer. Mr. Rohde joins uniQure from Basilea Pharmaceutica (SIX: BSLN) where from 2007 he was Chief Commercial Officer and member of the company's executive management committee with responsibility...

BioSurplus opens lab equipment showroom in Watertown

December 6, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

From left to right, Susan Windham-Bannister, president and CEO of the Massachusetts Life Sciences Center; Jackie Townsend, chief marketing officer of BioSurplus; and Brenda Fanara, executive director of the Watertown-Belmont Chamber of Commerce, attended a ribbon-cutting that took place Thursday morning at 57 Water St. in Watertown.

Moderna Therapeutics launches with $40M

December 6, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Moderna Therapeutics has been launched with a $40 million round of financing led by Cambridge-based Flagship Ventures, after 18 months of being incubated at Flagship VentureLabs.

IBM Expands the Power of Social Business with New Cloud, Mobile Advances

December 5, 2012 9:01 pm | by IBM | News | Comments

IBM today announced new social business software to help enterprise clients collaborate easily and securely in the cloud using the broadest range of mobile devices. The new IBM SmartCloud services include new social networking features and the release of IBM SmartCloud Docs, a cloud-based office productivity suite, which allows users to simultaneously collaborate on word processing, spreadsheet and presentation documents to improve productivity. E-mail this page Save to Digg this

Arno Therapeutics Reports Findings of New Diagnostic Technique the Potential to Identify Patients with Cancer Who May Respond to Treatment with Onapristone

December 5, 2012 8:00 pm | by The Associated Press | News | Comments

FLEMINGTON, N.J.--(BUSINESS WIRE)--Dec 5, 2012--Arno Therapeutics, Inc. (OTCBB: ARNI), a clinical-stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that researchers have identified a new immunohistochemistry technique for identifying activated...

Greatbatch, Inc. Elects Rudy A. Mazzocchi to its Board of Directors

December 5, 2012 4:50 pm | by The Associated Press | News | Comments

CLARENCE, N.Y.--(BUSINESS WIRE)--Dec 5, 2012--Greatbatch, Inc. (the “Greatbatch”) (NYSE: GB) announced that Rudy A. Mazzocchi has been elected to its Board of Directors. Mr. Mazzocchi also will serve on the Board’s Technology Development & Innovation and Corporate Governance & Nominating...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.